Login / Signup

Low-dose 5-azacytidine as preventive therapy for relapse of AML and MDS following allogeneic HCT.

J El-CheikhRadwan MassoudE FaresN KreidiehR MahfouzM CharafeddineM A Kharfan-DabajaA Bazarbachi
Published in: Bone marrow transplantation (2017)
Keyphrases
  • low dose
  • stem cell transplantation
  • high dose
  • acute myeloid leukemia
  • bone marrow
  • free survival
  • hematopoietic stem cell
  • cell cycle arrest
  • allogeneic hematopoietic stem cell transplantation
  • signaling pathway